coronavirus disease 2019
Showing 51 - 75 of >10,000
Convalescent Plasma for Treatment of Veterans With COVID-19
Completed
- Coronavirus Disease 2019 (COVID-19)
- COVID-19 convalescent plasma
-
Boston, Massachusetts
- +1 more
Jul 18, 2022
Covid-19 Trial in Falls Church (Convalescent plasma transfusion)
Terminated
- Covid-19
- Convalescent plasma transfusion
-
Falls Church, VirginiaInova Fairfax Medical Campus
Jan 5, 2022
Covid19, SARS (Severe Acute Respiratory Syndrome) Trial (Hydroxychloroquine, Vitamins and Minerals, Azithromycin)
Withdrawn
- Covid19
- SARS (Severe Acute Respiratory Syndrome)
- Hydroxychloroquine
- +2 more
- (no location specified)
Dec 5, 2021
Anxiety, Depressive Symptoms, Stress, Emotional Trial in Cambridge (StriveWeekly)
Completed
- Anxiety
- +2 more
- StriveWeekly
-
Cambridge, MassachusettsHarvard University
Aug 11, 2022
Coronavirus Disease 2019(COVID-19) Trial in Beijing (HH-120 Nasal Spray)
Recruiting
- Coronavirus Disease 2019(COVID-19)
- HH-120 Nasal Spray
-
Beijing, ChinaBeijing Ditan Hospital, Capital Medical University
Dec 20, 2022
AudibleHealth Dx AI/ML-Based Dx SaMD Using FCV-SDS in Diagnosis
Completed
- 2019 Novel Coronavirus Disease
- +8 more
- Diagnostic Test: Diagnostic Software as Medical Device
-
Sunrise, FloridaSunrise Research Institute
Jul 19, 2022
SaRS-Cov-2 Antibodies Following Exposure to Coronavirus Disease
Completed
- COVID-19 Infection
- SARS-CoV-2 antibodies
-
Vandoeuvre les Nancy, US And Canada Only, FranceCHRU de Nancy, Université de Lorraine
Jul 18, 2022
COVID-19 Trial in United States (mRNA-CR-04 vaccine 10µg, mRNA-CR-04 vaccine 30µg, mRNA-CR-04 vaccine 100µg)
Not yet recruiting
- COVID-19
- mRNA-CR-04 vaccine 10μg
- +3 more
-
San Diego, California
- +3 more
Aug 1, 2023
Covid19 Trial in Rochester (Virtual Intervention Program)
Not yet recruiting
- Covid19
- Virtual Intervention Program
-
Rochester, MinnesotaMayo Clinic in Rochester
Oct 3, 2022
COVID-19 Vaccine Trial in Argentina (Gamma Variant RBD-based ARVAC-CG vaccine, Omicron Variant RBD-based ARVAC-CG vaccine,
Recruiting
- COVID-19 Vaccine
- Gamma Variant RBD-based ARVAC-CG vaccine
- +3 more
-
Argentina, C.a.b.a., ArgentinaCentro de Educación Médica e Investigaciones Clínicas "Norberto
Feb 28, 2023
Disease Outcomes in Non-severe COVID-19 Patient
Recruiting
- COVID-19 Patient
-
Shanghai, Shanghai, ChinaRuijin Hospital affiliated to Shanghai Jiao Tong University Scho
Aug 4, 2022
Depression, Anxiety, Inflammation, COVID-19 Trial in Baltimore (Placebo, 300mg MYMD-1, 600mg MYMD-1)
Not yet recruiting
- Depression, Anxiety
- +2 more
- Placebo
- +2 more
-
Baltimore, MarylandJohns Hopkins Bayview Medical Center
Feb 7, 2022
Post-coronavirus Disease-2019 Fatigue
Completed
- Covid19
- Post-COVID / Long-COVID
- Cardiopulmonary stress test (CPET)
-
Petah Tikva, IsraelRabin Medical Center - Beilinson Hospital
Sep 30, 2021
The Practice of Providing Palliative Care in Situation of
Completed
- Covid19
- Distress, Emotional
- Questionnaire Survey
-
Brno, CzechiaUniversity Hospital Brno
Oct 14, 2021
Factors in Coronavirus Disease 2019 Following Intensive Care
Terminated
- Sarcopenia
- +2 more
- Standard care treatment for COVID-19 in Intensive Care Unit
-
Istanbul, TurkeyKoc University School of Medicine
Jul 25, 2022
Covid19, Coronavirus Disease 2019 Trial in Tehran (Tele-physiotherapy group, Control group)
Completed
- Covid19
- Coronavirus Disease 2019
- Tele-physiotherapy group
- Control group
-
Tehran, Iran, Islamic Republic ofImam Khomeini Hospital Complex
May 31, 2022
Coronavirus Disease 2019 Vaccination in Cancer Patients
Recruiting
- Malignancies Multiple
- COVID-19 vaccine hesitancy and acceptance survey
-
Hershey, PennsylvaniaPenn State Cancer Institute
Feb 28, 2022
A Retrospective Study in Patients With Mild to Moderate COVID-19
Recruiting
- COVID-19
-
Shanghai, Shanghai, ChinaShanghai Pudong Hospital
May 13, 2022
Study of Adults Vaccinated With AZD1222
Terminated
- Coronavirus Disease 2019 (COVID-19)
- None (Observational study)
-
Essen, GermanyResearch Site
Jun 27, 2022
COVID-19 (Coronavirus Disease 2019) Trial in Jilin (RAY1216 dose 1, RAY1216 dose 2, RAY1216 dose 3)
Completed
- COVID-19 (Coronavirus Disease 2019)
- RAY1216 dose 1
- +9 more
-
Jilin, ChinaThe First Hospital of Jilin University
Apr 13, 2023
Coronavirus Disease 2019 (COVID-19) Trial in United States (Garadacimab, Factor XIIa Antagonist Monoclonal Antibody, Placebo)
Completed
- Coronavirus Disease 2019 (COVID-19)
- Garadacimab, Factor XIIa Antagonist Monoclonal Antibody
- Placebo
-
Bradenton, Florida
- +13 more
Jan 20, 2022
Participants Hospitalized With Coronavirus Disease 2019 in Japan
Completed
- COVID-19
-
Minato-ku, Tokyo, Japan
- +1 more
May 9, 2022
Coronavirus Disease 2019, Vaccinia, Symptoms and Signs Trial in Basaksehir
Recruiting
- Coronavirus Disease 2019
- +2 more
-
Başaksehir, İstanbul, TurkeyDepartment of Obstetrics and Gynecology, Maternal-Fetal Medicine
May 5, 2022
Covid19 Trial in Vancouver (Povidone-iodine, Placebo)
Terminated
- Covid19
- Povidone-iodine
- Placebo
-
Vancouver, British Columbia, CanadaSt. Paul's Hospital
Jul 7, 2022